World ADC San Diego is the industry’s definitive antibody-drug conjugate (ADC) conference. It’s mission – to be the environment in which scientists can communicate problems and solutions; share novel data and forge networks to develop more clinically impactful ADCs.

Soricimed presented a poster entitled:

A Peptide-Paclitaxel Conjugate outperforms Paclitaxel in breast and ovarian cancer models where TRPV6 is over-expressed.World Congress of Antibody Drug Conjugates, San Francisco, October 2013

More Info